Bionano Genomics, Inc. (BNGO) Cash flow
Market cap
$12.87M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 1 | 1 | 1 | 3 | 10 | 14 | 14 | 10 |
| Stock-based compensation | 1 | 1 | 2 | 10 | 22 | 15 | 10 | 5 |
| Cash from operations | -19,943,847 | -29 | -38,314,378 | -72 | -125 | -125 | -69 | -16 |
| Capital expenditures | -331,716 | -61,056 | - | - | - | -2 | -0 | - |
| Cash from investing | -331,716 | -61,056 | -2,449,952 | -278 | 83 | 24 | 74 | -12,747,000 |
| Cash from financing | 36 | 30 | 62 | 336 | 23 | 114 | -14 | 24 |
| Free cash flow | - | - | - | - | ||||
| FCF margin (%) | - | - | - | - |